Literature DB >> 18616791

Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists.

M Wakkee1, M Lugtenberg, P I Spuls, E M de Jong, H B Thio, G P Westert, T Nijsten.   

Abstract

BACKGROUND: In 2003, the Dutch psoriasis guidelines were among the first evidence-based medicine guidelines in dermatology. Although pivotal, the implementation of dermatological guidelines has not been assessed.
OBJECTIVES: To evaluate various aspects that affect implementation of clinical guidelines such as knowledge, attitudes and practices among dermatologists.
METHODS: A cross-sectional anonymous postal survey was conducted among all Dutch dermatologists. In addition to questions about knowledge and practices, 24 items assessed guidelines attitudes. Factor analysis was applied to merge these items into attitudinal scales and multiple linear regression was used to identify predictors for these scales.
RESULTS: Of the 353 dermatologists, 161 (46%) completed the questionnaire. Almost all respondents were aware of the guidelines and 60% reported to have a decent knowledge of their content. Factor analysis retained 22 items divided into three scales: usefulness and content, barriers, and reliability. Apart from some disagreement on the user-friendliness and communication facilitating properties, the dermatologists' attitudes were generally positive. A larger volume of patients with psoriasis was associated with more frequent use of the guidelines [adjusted odds ratio (OR) = 2.42; 95% confidence interval (CI) 1.02-5.72]. Good familiarity predicted a more positive attitude towards the guidelines' usefulness and content (P < 0.001), perceived barriers (P < 0.001), and more frequent use in practice (adjusted OR = 8.38; 95% CI 3.08-22.81).
CONCLUSIONS: Dutch dermatologists seem to know and appreciate their psoriasis guidelines and use them more often when they have a larger psoriasis population. Enhancing the familiarity of the guidelines among users may result in a more positive attitude towards them and a higher frequency of use.

Entities:  

Mesh:

Year:  2008        PMID: 18616791     DOI: 10.1111/j.1365-2133.2008.08692.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Addressing comorbidities in psoriatic disease.

Authors:  Priya Patel; Cheryl F Rosen; Vinod Chandran; Yang Justine Ye; Dafna D Gladman
Journal:  Rheumatol Int       Date:  2017-11-28       Impact factor: 2.631

2.  Perceptions and attitudes of clinicians in Spain toward clinical practice guidelines and grading systems: a protocol for a qualitative study and a national survey.

Authors:  Anna Kotzeva; Ivan Solà; José Miguel Carrasco; Petra Díaz del Campo; Francisco Javier Gracia; Enrique Calderón; Idoia de Gaminde; Maria Dolors Estrada; Flora Martínez; Carola Orrego; Rafael Rotaeche; Flavia Salcedo; Paola Velázquez; Pablo Alonso-Coello
Journal:  BMC Health Serv Res       Date:  2010-12-03       Impact factor: 2.655

3.  Choice of Systemic Drugs for the Management of Moderate-to-severe Psoriasis: A Cross-country Comparison Based on National Health Insurance Data.

Authors:  Emilie Sbidian; Myriam Mezzarobba; Jason Shourick; Cécile Billionnet; Joël Coste; Alain Weill; Jérémie Rudant; Olivier Chosidow; Loes Hollestein; Tamar Nijsten
Journal:  Acta Derm Venereol       Date:  2021-06-22       Impact factor: 3.875

4.  Assessment, management, and incidence of neonatal jaundice in healthy neonates cared for in primary care: a prospective cohort study.

Authors:  Berthe A M van der Geest; Malou J S de Mol; Ivana S A Barendse; Johanna P de Graaf; Loes C M Bertens; Marten J Poley; Erwin Ista; René F Kornelisse; Irwin K M Reiss; Eric A P Steegers; Jasper V Been
Journal:  Sci Rep       Date:  2022-08-23       Impact factor: 4.996

5.  Rationing in the intensive care unit in case of full bed occupancy: a survey among intensive care unit physicians.

Authors:  Anke J M Oerlemans; Hub Wollersheim; Nelleke van Sluisveld; Johannes G van der Hoeven; Wim J M Dekkers; Marieke Zegers
Journal:  BMC Anesthesiol       Date:  2016-05-03       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.